NCT02365714

CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI)

A Pilot Study of Stereotactic Accelerated Partial Breast Irradiation (SAPBI) for Post-Menopausal Women (>50 y/o) With Ductal Carcinoma in Situ (DCIS) or Early Stage Breast Cancer

• Status: Terminated
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 2 (actual)
• Sponsor: Georgetown University · Academic / Other
• Sex: Female
• Age: 50 Years – 99 Years
• Healthy volunteers: Not accepted

Summary

This study will prospectively evaluate the technical feasibility, acute toxicity, late effects and oncologic outcomes of CyberKnife Stereotactic Accelerated Partial Breast Irradiation (CK-SAPBI) in early stage breast cancer. It will evaluate quality of life (QOL) issues as they relate to treatment-related side effects and cosmetic results.

Detailed description

This study will determine the feasibility, acute and late toxicity as well as oncologic outcomes following CK-SAPBI.

Conditions

• Breast Cancer
• DCIS
• Invasive Ductal Carcinoma

Interventions

Type	Name	Description
RADIATION	CK Stereotactic Accelerated Partial Breast Irradiation	Adjuvant radiation therapy will be delivered to the region of the lumpectomy cavity once daily for 5 treatments over 5-10 days.

Timeline

• Start date: 2015-02-01
• Primary completion: 2017-01-01
• Completion: 2017-01-01
• First posted: 2015-02-19
• Last updated: 2018-04-13
• Results posted: 2018-04-13

Locations

1 site across 1 country: United States